1
Home
Companies

Dishman Carbogen Amcis

Dishman Carbogen Amcis
Leadership team

Mr. Arpit Janmejay Vyas (Global MD & Director)

Ms. Deohooti Janmejay Vyas (Whole Time Director)

Mr. Harshil R. Dalal (Global Chief Financial Officer)

Products/ Services
Biotechnology, Medical Device, Pharmaceutical, Product Design
Number of Employees
1,000 - 20,000
Headquarters
Ahmedabad, Gujarat, India
Established
2007
Revenue
100M - 500M
Traded as
NSE:DCAL
Social Media
URL
https://imdcal.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. As of March 30, 2022, Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.
History

Dishman’s journey began in 1985 when it started as a supplier of active pharmaceutical ingredients (API). The company’s long-standing commitment to innovation has enabled it to become one of the leading Contract Research Organisations in the industry.

Mission
Our mission is to enable global pharmaceutical companies to reduce drug development timelines and cost by providing access to cutting edge technology and expertise.
Vision
Our vision is to be the “Partner of Choice” for drug discovery and development by delivering best-in-class services with a focus on innovation and technology.
Key Team

Dr. Stephan Fritschi (Exec. VP of Operation - CARBOGEN AMCIS)

Mr. Paolo Armanino (Chief Operating Officer of Indian Operations)

Ms. Shrima Gaurangbhai Dave (Compliance Officer & Company Sec.)

Mr. Dharmesh Desai (GM of Secretarial & Legal)

Mr. . HUZIFA (Sales Mang.)

Mr. Dieter Thueer (Global Head of HR)

Mr. Pascal Villemagne (Chief Exec. Officer of CARBOGEN AMCIS)

Recognition and Awards
Dishman Carbogen Amcis has received numerous rewards and recognitions like the Frost & Sullivan Recognition award for “CRO Service Provider of the Year”, the CPhI Award for “API Manufacturer of the Year” and the Tata Business Excellence Award for “Organisational Transformation”.
References

https://in.investing.com/equities/dishman-carbogen-amcis

https://finance.yahoo.com/quote/DCAL.NS/profile?p=DCAL.NS

https://www.crunchbase.com/organization/dishman-carbogen-amcis

https://imdcal.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Dishman Carbogen Amcis
Leadership team

Mr. Arpit Janmejay Vyas (Global MD & Director)

Ms. Deohooti Janmejay Vyas (Whole Time Director)

Mr. Harshil R. Dalal (Global Chief Financial Officer)

Products/ Services
Biotechnology, Medical Device, Pharmaceutical, Product Design
Number of Employees
1,000 - 20,000
Headquarters
Ahmedabad, Gujarat, India
Established
2007
Revenue
100M - 500M
Traded as
NSE:DCAL
Social Media
URL
https://imdcal.com